Velasquez Ruben Dario 4/A

4/A · STEPAN CO · Filed May 12, 2026

AI-generated summary of this filing

Updated May 12, 2026

Stepan (SCL) CFO Ruben Velasquez Receives Stock Awards

What Happened

Ruben Dario Velasquez, Chief Financial Officer of Stepan Company, was granted a mix of restricted stock units (RSUs) and performance-share awards. The filing shows 35.601 RSUs reported at $52.51 each (value $1,869) and three derivative/performance awards of 5,993; 2,996; and 8,586 shares (reported at $0 because they are contingent). Total shares awarded equal 17,610.601 (reported as ~17,611).

Key Details

Transaction dates and prices:
- 2026-02-27: 35.601 RSUs @ $52.51 each (reported value $1,869) — code A (award/grant).
- 2026-03-02: 5,993 performance shares @ $0 (derivative/contingent) — code A.
- 2026-03-02: 2,996 performance shares @ $0 (derivative/contingent) — code A.
- 2026-03-02: 8,586 performance shares @ $0 (derivative/contingent) — code A.
Shares owned after the transactions: not disclosed in this Form 4/A.
Vesting and contingencies:
- RSUs (F1/F2): each RSU converts to one share; vest ratably over three years beginning on the date shown.
- Performance shares (F3/F4): each represents one contingent share and vest only if specified performance goals are certified for the performance period ending December 31, 2028.
Filing status: This is an amended Form 4 (Form 4/A). The Original Form 4 was filed March 4, 2026; this amendment corrects a previously misstated SAR conversion/exercise price (see next item).

Context

Amendment detail (F5): The filing corrects an administrative error in a previously reported stock appreciation right (SAR) conversion/exercise price — the correct price is $50.06 (previously reported as $17.47). The amendment states no other aspects of the reported transaction were affected.
These awards are compensation (not open‑market purchases or sales); most of the shares are performance-based and may never vest if goals are unmet. For retail investors, awards signal management compensation alignment but are not the same as a direct purchase that indicates personal buying conviction.

Form 4/AAmended

Period: 2026-02-27

VP and Chief Financial Officer

Transactions

Award
Common Stock
2026-02-27$52.51/sh+35.601$1,869→ 35.601 total
Award
Restricted Stock Units
[F1][F2]
2026-03-02+5,993→ 5,993 total
From: 2027-03-02Exp: 2029-03-02→ Restricted Stock Units (5,993 underlying)
Award
Performance Shares
[F3][F4]
2026-03-02+2,996→ 2,996 total
→ Common Stock (2,996 underlying)
Award
Stock Appreciation Right
[F5][F2]
2026-03-02+8,586→ 8,586 total
Exercise: $50.06From: 2027-03-02Exp: 2036-03-03→ Common Stock (8,586 underlying)

Footnotes (5)

[F1]Each RSU represents a contingent right to receive one share of Stepan Company common stock.
[F2]Vest ratably over three years beginning on the date shown.
[F3]Each performance share represents a contingent right to receive one share of Stepan Company common stock.
[F4]The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
[F5]This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.

Signature

/s/ James A. Hart, attorney-in-fact for Ruben D. Velasquez|2026-05-12

1 file